Neuroprotective Effect of Genistein Against beta Amyloid-Induced Neurotoxicity
Journal of the Korean Neurological Association
;
: 174-182, 2003.
Article
in English
| WPRIM
| ID: wpr-109685
ABSTRACT
BACKGROUND:
Estrogen is beneficial to patients with Alzheimer's disease but has a limited clinical use due to its proliferative and oncogenic effects on non-neuronal estrogen responsive cells.METHODS:
In an attempt to find an estrogen substitute that retains the beneficial effects of estrogen with minimal side effects, we compared the neuroprotective and proliferative effects of genistein, a selective estrogen receptor betaagonist, with those of estrogen.RESULTS:
Genistein and 17beta-estradiol showed comparable levels of protection against Abeta-induced death of cultured SH-SY5Y human neuroblastoma cells, which was blocked by an estrogen receptor antagonist, ICI 182, 780. On the other hand, 17beta-estradiol, but not geninstein, induced proliferation of uterine endometrial cells.CONCLUSIONS:
Our results suggest genistein as a potential alternative to estrogen in the treatment of Alzheimer's disease.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Cell Death
/
Neuroprotective Agents
/
Genistein
/
Estrogens
/
Alzheimer Disease
/
Hand
/
Neuroblastoma
Limits:
Humans
Language:
English
Journal:
Journal of the Korean Neurological Association
Year:
2003
Type:
Article
Similar
MEDLINE
...
LILACS
LIS